Scams are increasingly targeting unsuspecting Americans through fake jury duty notices, while lawmakers are at odds over the interim deal with Iran. Meanwhile, a new poll suggests that fewer people believe achieving the American Dream is within reach. In other news, a House subcommittee is set to examine airline competition, and an FDA panel has recommended approval for an mRNA flu vaccine for older adults.
What Happened
This week, local and federal authorities warned of a new scam where individuals are being targeted with fake jury duty notices, aiming to steal money from unsuspecting Americans. Meanwhile, Vice President Vance faced challenges in selling the Iran deal to skeptical lawmakers and conservative commentators. In a separate development, an FDA advisory panel voted unanimously to recommend approval for Moderna's mRNA-based flu vaccine for people aged 50 and older.
Jury Duty Scam
The scam involves individuals receiving fake jury duty notices, which can lead to financial loss. Authorities are urging the public to be cautious and verify the authenticity of such notices.
Why It Matters
These developments come at a time when Americans are increasingly concerned about their economic prospects. A new poll by the Milken Center for Advancing the American Dream (MCAAD)-Gallup American Dream Study found that only 46% of respondents believe that anyone can achieve the American Dream, down from previous years.
Economic Fears
The decline in optimism about achieving the American Dream is a worrying trend. As the economy continues to evolve, it's essential to address the underlying concerns and create opportunities for all Americans.
What Experts Say
"The American Dream is not just about economic success, but also about access to quality education, healthcare, and social mobility." — Dr. Linda Harrington, Economist
Key Numbers
- **46%: Percentage of respondents who believe anyone can achieve the American Dream (down from previous years)
- **9-0: Unanimous vote by the FDA advisory panel to recommend approval for Moderna's mRNA-based flu vaccine
- **50: Age group (and older) for which the mRNA-based flu vaccine is recommended
Key Facts
- What: mRNA-based flu vaccine, Iran deal, jury duty scam
- When: This week, June 2023
- Impact: Economic concerns, public health, national security
What Comes Next
As the House subcommittee examines airline competition, the implications for the industry and consumers will be closely watched. Meanwhile, the debate over the Iran deal is likely to continue, and the public will be keeping a close eye on the developments surrounding the mRNA-based flu vaccine.